Impact of diagnosis to ablation time on clinical outcomes in patients with atrial fibrillation: post hoc analysis of the CABANA trial.

Another study attempted to identify lower and upper DAT thresholds for reducing AF recurrence, but observed a decreasing trend in AF recurrence risk as DAT shortened without a clear cutoff, while delayed AFCA conferred diminishing benefits, particularly beyond 3 years [ 26 ].

also in 47,180 other papers